| Product Code: ETC7548515 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, 2021 & 2031F |
3.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Industry Life Cycle |
3.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Porter's Five Forces |
3.5 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of NTRK fusion gene-positive advanced solid tumors in India |
4.2.2 Growing awareness among healthcare professionals about targeted therapies for NTRK fusion gene-positive tumors |
4.2.3 Advancements in precision medicine and personalized treatment options for patients with NTRK fusion gene-positive tumors |
4.3 Market Restraints |
4.3.1 Limited accessibility and affordability of targeted therapies for NTRK fusion gene-positive tumors in India |
4.3.2 Challenges in accurate diagnosis and identification of NTRK fusion gene-positive tumors |
4.3.3 Regulatory hurdles and delays in the approval of new targeted therapies in the Indian market |
5 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Trends |
6 India NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Types |
6.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Cancer Centers, 2021- 2031F |
6.2.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Others, 2021- 2031F |
7 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Import-Export Trade Statistics |
7.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Export to Major Countries |
7.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Imports from Major Countries |
8 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Key Performance Indicators |
8.1 Number of healthcare facilities offering genetic testing for NTRK fusion gene-positive tumors |
8.2 Adoption rate of targeted therapies among patients with NTRK fusion gene-positive tumors |
8.3 Rate of successful treatment outcomes and patient responses to targeted therapies |
8.4 Investment in research and development of new targeted therapies for NTRK fusion gene-positive tumors |
8.5 Number of clinical trials evaluating the efficacy of targeted therapies for NTRK fusion gene-positive tumors |
9 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Opportunity Assessment |
9.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Competitive Landscape |
10.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenue Share, By Companies, 2024 |
10.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here